The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike shots, this method offers a more convenient way to administer GLP-1 drugs. These https://matteoykze926278.csublogs.com/48820780/glp-1-patches-a-new-approach-to-diabetes-control